ESRP1 and small cell lung carcinoma: The study showed that ESRP1 reverses the chemoresistance of SCLC by regulating the selective splicing of coactivator-associated arginine methyltransferase 1 (CARM1) to inhibit the TGF-β/Smad signaling pathway, thereby enhancing its chemosensitivity (47).